Is The ASA On Ozempic?

The ASA has issued its Annual Report on its work in 2024. And it's very slim. Not that it was bloated before (we don't want to be rude about previous Annual Reports). In fact, it reflects two buzzwords from 2024: Ozempic and AI.

As usual, the report contains a smorgasbord of stats. In 2024, the ASA and CAP secured the amendment or withdrawal of 33,903 ads. 94% of these came from its proactive ad monitoring work scanning 28 million ads - illustrating how the ASA no longer waits for consumers or competitors to make complaints. Many of the ads covered prescription-only medicines, cosmetic surgery overseas, whiskey cask investments, vapes, mini-heaters and green claims. The ASA also used its AI tools in areas such as influencer marketing, financial advertising and gambling.